Abstract | BACKGROUND/AIM: PATIENTS AND METHODS: RESULTS: CONCLUSION: Guideline compliance was very low. Although not statistically significant, there was a trend for reduced CINV and improved disease control for triple versus double antiemetics, suggesting that triple antiemetics should be considered for HEC, especially in young female patients with non-Hodgkin lymphoma receiving CHOP-like regimens.
|
Authors | Isao Yoshida, Kazuo Tamura, Toshihiro Miyamoto, Mototsugu Shimokawa, Yasushi Takamatsu, Yasuhito Nanya, Itaru Matsumura, Moritaka Gotoh, Tadahiko Igarashi, Tsutomu Takahashi, Keisuke Aiba, Kyoya Kumagai, Kenichi Ishizawa, Naoki Kurita, Noriko Usui, Kiyohiko Hatake |
Journal | In vivo (Athens, Greece)
(In Vivo)
2019 Jul-Aug
Vol. 33
Issue 4
Pg. 1355-1362
ISSN: 1791-7549 [Electronic] Greece |
PMID | 31280230
(Publication Type: Journal Article)
|
Copyright | Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Aged
- Antiemetics
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Female
- Health Care Surveys
- Hematologic Neoplasms
(complications, drug therapy, epidemiology)
- Humans
- Incidence
- Japan
(epidemiology)
- Male
- Middle Aged
- Nausea
(diagnosis, epidemiology, etiology, prevention & control)
- Premedication
- Severity of Illness Index
- Surveys and Questionnaires
- Treatment Outcome
- Vomiting
(diagnosis, epidemiology, etiology, prevention & control)
|